Literature DB >> 22305448

Incidentalomas: a "disease" of modern imaging technology.

Jennifer Wagner1, David C Aron.   

Abstract

The evolution of new diagnostic techniques has revolutionized the practice of medicine and in fact, the nature of medicine itself. Technology has also expanded the "visual" field of medicine: the naked eye was assisted by the light microscope and then electron microscope to see smaller and smaller features while radiology has permitted "non-invasive" identification of internal structures. However, there are unintended consequences one of which is the discovery of an anomaly during the course of looking for something else - incidental findings and incidentalomas. Technology in general and imaging specifically offer much in service to physicians and their patients. However, it behoves physicians to ensure that technology supplements but does not replace good clinical judgment. This essay aims to put the issue of incidental findings related to advancing technology (especially imaging technology) into a broader context. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22305448     DOI: 10.1016/j.beem.2011.08.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  10 in total

1.  Incremental diagnostic utility of gastric distension FDG PET/CT.

Authors:  Pierre-Yves Le Roux; Cuong P Duong; Carlos S Cabalag; Bimal K Parameswaran; Jason Callahan; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-21       Impact factor: 9.236

Review 2.  Autonomous cortisol secretion in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Miguel Antonio Sampedro Núñez; Mónica Marazuela
Journal:  Endocrine       Date:  2019-03-07       Impact factor: 3.633

3.  How to Draw the Line Between Health and Disease? Start with Suffering.

Authors:  Bjørn Hofmann
Journal:  Health Care Anal       Date:  2021-04-29

4.  Incidental Findings in Dental Radiology are Concerning for Family Doctors.

Authors:  Paul Monsarrat; Antoine Galibourg; Karim Nasr; Norbert Telmon; Delphine Maret
Journal:  Open Med (Wars)       Date:  2019-07-31

5.  Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.

Authors:  Marta Araujo-Castro; Ana García Cano; Lucía Jiménez Mendiguchía; Héctor F Escobar-Morreale; Pablo Valderrábano
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

6.  Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.

Authors:  M Araujo-Castro; C Robles Lázaro; P Parra Ramírez; R García Centeno; P Gracia Gimeno; M T Fernández-Ladreda; M A Sampedro Núñez; M Marazuela; H F Escobar-Morreale; P Valderrabano
Journal:  J Endocrinol Invest       Date:  2021-03-08       Impact factor: 4.256

7.  Breast findings incidentally detected on body MRI.

Authors:  Bianca Bignotti; Giulia Succio; Francesca Nosenzo; Michela Perinetti; Licia Gristina; Stella Barbagallo; Lucia Secondini; Massimo Calabrese; Alberto Tagliafico
Journal:  Springerplus       Date:  2016-06-18

8.  WFUMB position paper on the management incidental findings: adrenal incidentaloma.

Authors:  Christoph F Dietrich; Jean Michel Correas; Yi Dong; Christian Nolsoe; Susan Campbell Westerway; Christian Jenssen
Journal:  Ultrasonography       Date:  2019-07-09

9.  Visualizing the Invisible: Invisible Waste in Diagnostic Imaging.

Authors:  Bjørn Hofmann; Eivind Richter Andersen; Elin Kjelle
Journal:  Healthcare (Basel)       Date:  2021-12-07

10.  Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Paola Parra Ramírez; Cristina Robles Lázaro; Rogelio García Centeno; Paola Gracia Gimeno; Mariana Tomé Fernández-Ladreda; Miguel Antonio Sampedro Núñez; Mónica Marazuela; Héctor F Escobar-Morreale; Pablo Valderrabano
Journal:  Hormones (Athens)       Date:  2021-07-17       Impact factor: 2.885

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.